PLASMA CYTOKINES LEVELS IN PATIENTS UNDERGOING LONG-TERM HAEMODIALYSIS

Аbstract.  Patients  with  end-stage  renal  disease  need  their  kidney  functions  to  be  replaced.  Chronic haemodialysis represents a most common method of such substitution treatment. This procedure results in successful survival of such patients for years. Chronic haemodialysis is accompanie...

Full description

Bibliographic Details
Main Authors: D. S. Polyakov, O. M. Domashenko, P. V. Beloborodov, K. A. Syssoev, M. M. Shavlovsky, Areg A. Totolian
Format: Article
Language:Russian
Published: SPb RAACI 2014-07-01
Series:Medicinskaâ Immunologiâ
Subjects:
Online Access:https://www.mimmun.ru/mimmun/article/view/513
id doaj-b9f4b999df6742ceae3f4b1e2761a647
record_format Article
spelling doaj-b9f4b999df6742ceae3f4b1e2761a6472021-07-29T09:02:26ZrusSPb RAACIMedicinskaâ Immunologiâ1563-06252313-741X2014-07-01132-321121810.15789/1563-0625-2011-2-3-211-218510PLASMA CYTOKINES LEVELS IN PATIENTS UNDERGOING LONG-TERM HAEMODIALYSISD. S. PolyakovO. M. DomashenkoP. V. BeloborodovK. A. SyssoevM. M. ShavlovskyAreg A. TotolianАbstract.  Patients  with  end-stage  renal  disease  need  their  kidney  functions  to  be  replaced.  Chronic haemodialysis represents a most common method of such substitution treatment. This procedure results in successful survival of such patients for years. Chronic haemodialysis is accompanied by a complication which is known as β2-microglobulin amyloidosis. In this case, amyloid substance consisting of β2-microglobulin (β2-MG) accumulates in bones, ligaments and joints. Biological causes of β2-MG amyloidosis are still not established. To elucidate the role of inflammation in the pathogenesis of β2-MG amyloidosis, the levels of  IL-2,  IL-4,  IL-6,  IL-8,  IL-10,  GM-CSF,  IFNγ, TNFα were quantified in plasma of patients undergoing  long-term haemodialysis. Mean amounts of all the mentioned cytokines in haemodialysis patients proved to be significantly higher than in control group consisting of healthy subjects. When comparing a group receiving standard  dialysis  procedure  versus  a  subgroup  receiving  haemodiafiltration,  a  single  reliable  difference  was revealed for GM-CSF levels (p < 0.04), without any differences shown for other cytokines. With increasing terms of chronic haemodialysis, the levels of IL-2, IL-4, IL-6, IL-8, GM-CSF, IFNγ, TNFα were increased, or, at least, they did not decrease. After three years of dialysis, IL-10 concentrations were statistically indistinguishable from normal levels. In patients undergoing haemodiafiltration, plasma levels of IL-2, IL-4, IL-8, GM-CSF, IFNγ, TNFα did not drop with increasing terms of dialysis. The levels of IL-6 and IL-10 decreased after three years of dialysis, to near-normal levels.In general, these results suggest that IL-10 and IL-6 may be regarded as candidates for further studies as potential markers of β2-microglobulin amyloidosis. (Med. Immunol., 2011, vol. 13, N 2-3, pp 211-218)https://www.mimmun.ru/mimmun/article/view/513cytokineshaemodialysisinflammationβ2-microglobulinamyloidosis
collection DOAJ
language Russian
format Article
sources DOAJ
author D. S. Polyakov
O. M. Domashenko
P. V. Beloborodov
K. A. Syssoev
M. M. Shavlovsky
Areg A. Totolian
spellingShingle D. S. Polyakov
O. M. Domashenko
P. V. Beloborodov
K. A. Syssoev
M. M. Shavlovsky
Areg A. Totolian
PLASMA CYTOKINES LEVELS IN PATIENTS UNDERGOING LONG-TERM HAEMODIALYSIS
Medicinskaâ Immunologiâ
cytokines
haemodialysis
inflammation
β2-microglobulin
amyloidosis
author_facet D. S. Polyakov
O. M. Domashenko
P. V. Beloborodov
K. A. Syssoev
M. M. Shavlovsky
Areg A. Totolian
author_sort D. S. Polyakov
title PLASMA CYTOKINES LEVELS IN PATIENTS UNDERGOING LONG-TERM HAEMODIALYSIS
title_short PLASMA CYTOKINES LEVELS IN PATIENTS UNDERGOING LONG-TERM HAEMODIALYSIS
title_full PLASMA CYTOKINES LEVELS IN PATIENTS UNDERGOING LONG-TERM HAEMODIALYSIS
title_fullStr PLASMA CYTOKINES LEVELS IN PATIENTS UNDERGOING LONG-TERM HAEMODIALYSIS
title_full_unstemmed PLASMA CYTOKINES LEVELS IN PATIENTS UNDERGOING LONG-TERM HAEMODIALYSIS
title_sort plasma cytokines levels in patients undergoing long-term haemodialysis
publisher SPb RAACI
series Medicinskaâ Immunologiâ
issn 1563-0625
2313-741X
publishDate 2014-07-01
description Аbstract.  Patients  with  end-stage  renal  disease  need  their  kidney  functions  to  be  replaced.  Chronic haemodialysis represents a most common method of such substitution treatment. This procedure results in successful survival of such patients for years. Chronic haemodialysis is accompanied by a complication which is known as β2-microglobulin amyloidosis. In this case, amyloid substance consisting of β2-microglobulin (β2-MG) accumulates in bones, ligaments and joints. Biological causes of β2-MG amyloidosis are still not established. To elucidate the role of inflammation in the pathogenesis of β2-MG amyloidosis, the levels of  IL-2,  IL-4,  IL-6,  IL-8,  IL-10,  GM-CSF,  IFNγ, TNFα were quantified in plasma of patients undergoing  long-term haemodialysis. Mean amounts of all the mentioned cytokines in haemodialysis patients proved to be significantly higher than in control group consisting of healthy subjects. When comparing a group receiving standard  dialysis  procedure  versus  a  subgroup  receiving  haemodiafiltration,  a  single  reliable  difference  was revealed for GM-CSF levels (p < 0.04), without any differences shown for other cytokines. With increasing terms of chronic haemodialysis, the levels of IL-2, IL-4, IL-6, IL-8, GM-CSF, IFNγ, TNFα were increased, or, at least, they did not decrease. After three years of dialysis, IL-10 concentrations were statistically indistinguishable from normal levels. In patients undergoing haemodiafiltration, plasma levels of IL-2, IL-4, IL-8, GM-CSF, IFNγ, TNFα did not drop with increasing terms of dialysis. The levels of IL-6 and IL-10 decreased after three years of dialysis, to near-normal levels.In general, these results suggest that IL-10 and IL-6 may be regarded as candidates for further studies as potential markers of β2-microglobulin amyloidosis. (Med. Immunol., 2011, vol. 13, N 2-3, pp 211-218)
topic cytokines
haemodialysis
inflammation
β2-microglobulin
amyloidosis
url https://www.mimmun.ru/mimmun/article/view/513
work_keys_str_mv AT dspolyakov plasmacytokineslevelsinpatientsundergoinglongtermhaemodialysis
AT omdomashenko plasmacytokineslevelsinpatientsundergoinglongtermhaemodialysis
AT pvbeloborodov plasmacytokineslevelsinpatientsundergoinglongtermhaemodialysis
AT kasyssoev plasmacytokineslevelsinpatientsundergoinglongtermhaemodialysis
AT mmshavlovsky plasmacytokineslevelsinpatientsundergoinglongtermhaemodialysis
AT aregatotolian plasmacytokineslevelsinpatientsundergoinglongtermhaemodialysis
_version_ 1721249982620631040